Alkermes PLC (NASDAQ:ALKS) Director Richard F. Pops sold 30,000 shares of the business’s stock in a transaction on Tuesday, November 22nd. The shares were sold at an average price of $58.66, for a total transaction of $1,759,800.00. Following the transaction, the director now owns 638,962 shares in the company, valued at approximately $37,481,510.92. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Alkermes PLC (NASDAQ:ALKS) traded down 1.45% during trading on Tuesday, reaching $58.34. 950,789 shares of the company traded hands. The company’s 50-day moving average price is $51.15 and its 200 day moving average price is $47.04. The firm’s market capitalization is $8.87 billion. Alkermes PLC has a 52 week low of $27.14 and a 52 week high of $80.71.

Alkermes PLC (NASDAQ:ALKS) last released its quarterly earnings results on Wednesday, November 2nd. The company reported ($0.09) earnings per share for the quarter, missing the consensus estimate of ($0.06) by $0.03. The company earned $180.20 million during the quarter, compared to the consensus estimate of $186.39 million. Alkermes PLC had a negative net margin of 36.92% and a negative return on equity of 12.75%. The business’s revenue was up 18.0% on a year-over-year basis. During the same quarter last year, the firm earned ($0.19) EPS. On average, equities research analysts expect that Alkermes PLC will post ($0.20) EPS for the current year.

Insider Buying and Selling by Quarter for Alkermes PLC (NASDAQ:ALKS)

Hedge funds have recently added to or reduced their stakes in the stock. LS Investment Advisors LLC boosted its stake in Alkermes PLC by 23.6% in the second quarter. LS Investment Advisors LLC now owns 2,846 shares of the company’s stock valued at $123,000 after buying an additional 544 shares during the period. Glenmede Trust Co. NA boosted its stake in shares of Alkermes PLC by 2,458.1% in the second quarter. Glenmede Trust Co. NA now owns 3,300 shares of the company’s stock worth $142,000 after buying an additional 3,171 shares during the period. Mn Services Vermogensbeheer B.V. boosted its stake in shares of Alkermes PLC by 3.4% in the second quarter. Mn Services Vermogensbeheer B.V. now owns 3,829 shares of the company’s stock worth $149,000 after buying an additional 127 shares during the period. Strs Ohio boosted its stake in shares of Alkermes PLC by 29.6% in the second quarter. Strs Ohio now owns 4,050 shares of the company’s stock worth $175,000 after buying an additional 925 shares during the period. Finally, Independent Portfolio Consultants Inc. acquired a new stake in shares of Alkermes PLC during the second quarter worth approximately $179,000. Institutional investors and hedge funds own 94.67% of the company’s stock.

A number of research analysts recently issued reports on the stock. Jefferies Group reiterated a “buy” rating and set a $70.00 target price on shares of Alkermes PLC in a research report on Thursday, November 17th. Cowen and Company reiterated a “buy” rating on shares of Alkermes PLC in a research report on Wednesday, November 2nd. Morgan Stanley upgraded shares of Alkermes PLC from an “underweight” rating to a “hold” rating and set a $62.00 target price on the stock in a research report on Friday, October 21st. Leerink Swann upped their price objective on shares of Alkermes PLC from $57.00 to $70.00 and gave the stock an “outperform” rating in a report on Friday, October 21st. Finally, Credit Suisse Group AG upped their price objective on shares of Alkermes PLC from $52.00 to $70.00 and gave the stock an “outperform” rating in a report on Friday, October 21st. One investment analyst has rated the stock with a sell rating, three have given a hold rating and seven have given a buy rating to the company. The company has an average rating of “Buy” and a consensus price target of $61.64.

ILLEGAL ACTIVITY WARNING: “Alkermes PLC (ALKS) Director Richard F. Pops Sells 30,000 Shares” was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this article on another website, it was stolen and republished in violation of United States & international trademark & copyright laws. The original version of this article can be viewed at https://www.thecerbatgem.com/2016/11/22/alkermes-plc-alks-director-richard-f-pops-sells-30000-shares.html.

Alkermes PLC Company Profile

Alkermes Public Limited Company is a biopharmaceutical company. The Company is engaged in researching, developing and commercializing, both with partners and on its own, pharmaceutical products that are designed to address medical needs of patients in therapeutic areas. The Company has a portfolio of approximately 20 products and a clinical pipeline of product candidates that address central nervous system (CNS) disorders, such as schizophrenia, depression, addiction and multiple sclerosis.

5 Day Chart for NASDAQ:ALKS

Receive News & Stock Ratings for Alkermes PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alkermes PLC and related stocks with our FREE daily email newsletter.